{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:30:45Z","timestamp":1786408245789,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA188427"],"award-info":[{"award-number":["R01CA188427"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM137452"],"award-info":[{"award-number":["R35GM137452"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein tyrosine kinase 6 (PTK6) has context-specific, kinase-dependent and -independent functions in normal cells and cancer. In prostate cells, nuclear PTK6 suppresses growth, while active membrane-associated PTK6 promotes oncogenic signaling. Unlike SRC-family kinases, PTK6 is not modified by lipidation to promote membrane association. Although arginine residues in the PTK6 SH2 domain were previously linked to lipid binding, we found they are instead critical for protein stability and arginine methylation. Mutation of R131\/R136 or R132 impaired PTK6 ubiquitination and its association with a Cullin-1-RING ubiquitin ligase complex, and its half-life increased from one hour to over 24\u2009h. We show that PTK6 is targeted by PRMT1 and mutation of PTK6 R131\/R136 or R132, or treatment with the type 1 PRMT inhibitor GSK3368715, leads to decreased arginine methylation, increased PTK6 protein stability and impaired PTK6 association with its substrates. In prostate cancer cells, ectopic expression of mutant PTK6 R131\/R136 or R132 leads to reduced proliferation, anchorage-independent growth, and cell migration and invasion, when compared with wild type PTK6, even though higher levels of mutant protein are expressed. These results indicate that arginine methylation is a key regulatory switch for PTK6 signaling and protein turnover and may be central for the execution of its diverse context-specific functions. Mutation of PTK6 arginine residues has been reported in some cancers, which may contribute to disease-specific PTK6 expression and signaling.<\/jats:p>","DOI":"10.1038\/s41419-026-08933-5","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:56:39Z","timestamp":1780682199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein tyrosine kinase-6 is post-translationally regulated by arginine methylation and ubiquitination"],"prefix":"10.1038","volume":"17","author":[{"given":"Liping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-3174","authenticated-orcid":false,"given":"Milica B.","family":"Gilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-4974","authenticated-orcid":false,"given":"Katarina","family":"Vlajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2197-9241","authenticated-orcid":false,"given":"Shafi","family":"Kuchay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7448-8625","authenticated-orcid":false,"given":"Angela L.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"8933_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188432","volume":"1874","author":"MB Gilic","year":"2020","unstructured":"Gilic MB, Tyner AL. Targeting protein tyrosine kinase 6 in cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188432.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8933_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/eci.12050","volume":"43","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Tyner AL. Context-specific protein tyrosine kinase 6 (PTK6) signalling in prostate cancer. Eur J Clin Invest. 2013;43:397\u2013404.","journal-title":"Eur J Clin Invest"},{"key":"8933_CR3","first-page":"66","volume":"1806","author":"PM Brauer","year":"2010","unstructured":"Brauer PM, Tyner AL. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK. Biochim Biophys Acta. 2010;1806:66\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"8933_CR4","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1038\/sj.onc.1206465","volume":"22","author":"JJ Derry","year":"2003","unstructured":"Derry JJ, Prins GS, Ray V, Tyner AL. Altered localization and activity of the intracellular tyrosine kinase BRK\/Sik in prostate tumor cells. Oncogene. 2003;22:4212\u201320.","journal-title":"Oncogene"},{"key":"8933_CR5","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.4161\/cc.9.20.13518","volume":"9","author":"PM Brauer","year":"2010","unstructured":"Brauer PM, Zheng Y, Wang L, Tyner AL. Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells. Cell Cycle. 2010;9:4190\u20139.","journal-title":"Cell Cycle"},{"key":"8933_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1242\/jcs.053264","volume":"123","author":"HL Palka-Hamblin","year":"2010","unstructured":"Palka-Hamblin HL, Gierut JJ, Bie W, Brauer PM, Zheng Y, Asara JM, et al. Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6. J Cell Sci. 2010;123:236\u201345.","journal-title":"J Cell Sci"},{"key":"8933_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1074\/jbc.M111.298117","volume":"287","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Asara JM, Tyner AL. Protein-tyrosine Kinase 6 Promotes Peripheral Adhesion Complex Formation and Cell Migration by Phosphorylating p130 CRK-associated Substrate. J Biol Chem. 2012;287:148\u201358.","journal-title":"J Biol Chem"},{"key":"8933_CR8","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1073\/pnas.82.14.4625","volume":"82","author":"MP Kamps","year":"1985","unstructured":"Kamps MP, Buss JE, Sefton BM. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation. Proc Natl Acad Sci USA. 1985;82:4625\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8933_CR9","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1038\/onc.2012.427","volume":"32","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Gierut J, Wang Z, Miao J, Asara JM, Tyner AL. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT. Oncogene. 2013;32:4304\u201312.","journal-title":"Oncogene"},{"key":"8933_CR10","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1158\/0008-5472.CAN-13-0443","volume":"73","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Wang Z, Bie W, Brauer PM, Perez White BE, Li J, et al. PTK6 activation at the membrane regulates epithelial-mesenchymal transition in prostate cancer. Cancer Res. 2013;73:5426\u201337.","journal-title":"Cancer Res"},{"key":"8933_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01574-5","volume":"8","author":"DJ Wozniak","year":"2017","unstructured":"Wozniak DJ, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner ML, Bie W, et al. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer. Nat Commun. 2017;8:1508.","journal-title":"Nat Commun"},{"key":"8933_CR12","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.18632\/oncotarget.2153","volume":"5","author":"M Peng","year":"2014","unstructured":"Peng M, Emmadi R, Wang Z, Wiley EL, Gann PH, Khan SA, et al. PTK6\/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors. Oncotarget. 2014;5:6038\u201348.","journal-title":"Oncotarget"},{"key":"8933_CR13","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/jid.2015.166","volume":"135","author":"MI Chastkofsky","year":"2015","unstructured":"Chastkofsky MI, Bie W, Ball-Kell SM, He YY, Tyner AL. Protein Tyrosine Kinase 6 Regulates UVB-Induced Signaling and Tumorigenesis in Mouse Skin. J Investigative Dermatol. 2015;135:2492\u2013501.","journal-title":"J Investigative Dermatol"},{"key":"8933_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2016.01.027","volume":"62","author":"MJ Park","year":"2016","unstructured":"Park MJ, Sheng R, Silkov A, Jung DJ, Wang ZG, Xin Y, et al. SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins. Mol Cell. 2016;62:7\u201320.","journal-title":"Mol Cell"},{"key":"8933_CR15","doi-asserted-by":"publisher","first-page":"29700","DOI":"10.1074\/jbc.M313185200","volume":"279","author":"E Hong","year":"2004","unstructured":"Hong E, Shin J, Kim HI, Lee ST, Lee W. Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain. J Biol Chem. 2004;279:29700\u20138.","journal-title":"J Biol Chem"},{"key":"8933_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","volume":"20","author":"E Guccione","year":"2019","unstructured":"Guccione E, Richard S. The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019;20:642\u201357.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8933_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat Rev Drug Discov. 2021;20:509\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"8933_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/ncb2731","volume":"15","author":"S Kuchay","year":"2013","unstructured":"Kuchay S, Duan S, Schenkein E, Peschiaroli A, Saraf A, Florens L, et al. FBXL2- and PTPL1-mediated degradation of p110-free p85beta regulatory subunit controls the PI(3)K signalling cascade. Nat Cell Biol. 2013;15:472\u201380.","journal-title":"Nat Cell Biol"},{"key":"8933_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114783","volume":"43","author":"SA Bhat","year":"2024","unstructured":"Bhat SA, Vasi Z, Jiang L, Selvaraj S, Ferguson R, Salarvand S, et al. Geranylgeranylated SCF(FBXO10) regulates selective outer mitochondrial membrane proteostasis and function. Cell Rep. 2024;43:114783.","journal-title":"Cell Rep"},{"key":"8933_CR20","doi-asserted-by":"publisher","first-page":"34634","DOI":"10.1074\/jbc.M203877200","volume":"277","author":"H Qiu","year":"2002","unstructured":"Qiu H, Miller WT. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J Biol Chem. 2002;277:34634\u201341.","journal-title":"J Biol Chem"},{"key":"8933_CR21","doi-asserted-by":"publisher","first-page":"30956","DOI":"10.1074\/jbc.271.48.30956","volume":"271","author":"T Kamalati","year":"1996","unstructured":"Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, et al. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J Biol Chem. 1996;271:30956\u201363.","journal-title":"J Biol Chem"},{"key":"8933_CR22","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1128\/MCB.00024-10","volume":"30","author":"Y Zheng","year":"2010","unstructured":"Zheng Y, Peng M, Wang Z, Asara JM, Tyner AL. Protein tyrosine kinase 6 directly phosphorylates AKT and promotes AKT activation in response to epidermal growth factor. Mol Cell Biol. 2010;30:4280\u201392.","journal-title":"Mol Cell Biol"},{"key":"8933_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102584","volume":"298","author":"WM Alwanian","year":"2022","unstructured":"Alwanian WM, Vlajic K, Bie W, Kajdacsy-Balla A, Tyner AL. Protein tyrosine kinase 6 regulates activation of SRC kinase. J Biol Chem. 2022;298:102584.","journal-title":"J Biol Chem"},{"key":"8933_CR24","doi-asserted-by":"publisher","first-page":"pl6","DOI":"10.1126\/stke.2002.129.pl6","volume":"2002","author":"S Dowler","year":"2002","unstructured":"Dowler S, Kular G, Alessi DR. Protein lipid overlay assay. Sci STKE. 2002;2002:pl6.","journal-title":"Sci STKE"},{"key":"8933_CR25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/sj.bjc.6604660","volume":"99","author":"M Aubele","year":"2008","unstructured":"Aubele M, Walch AK, Ludyga N, Braselmann H, Atkinson MJ, Luber B, et al. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer. 2008;99:1089\u201395.","journal-title":"Br J Cancer"},{"key":"8933_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BJ20120803","volume":"447","author":"SA Kang","year":"2012","unstructured":"Kang SA, Cho HS, Yoon JB, Chung IK, Lee ST. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. Biochem J. 2012;447:313\u201320.","journal-title":"Biochem J"},{"key":"8933_CR27","doi-asserted-by":"publisher","first-page":"4630","DOI":"10.1073\/pnas.1422313112","volume":"112","author":"Y Yoshida","year":"2015","unstructured":"Yoshida Y, Saeki Y, Murakami A, Kawawaki J, Tsuchiya H, Yoshihara H, et al. A comprehensive method for detecting ubiquitinated substrates using TR-TUBE. Proc Natl Acad Sci USA. 2015;112:4630\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8933_CR28","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1016\/j.molcel.2021.09.011","volume":"81","author":"J Xu","year":"2021","unstructured":"Xu J, Richard S. Cellular pathways influenced by protein arginine methylation: Implications for cancer. Mol Cell. 2021;81:4357\u201368.","journal-title":"Mol Cell"},{"key":"8933_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1053\/j.gastro.2011.06.071","volume":"141","author":"J Gierut","year":"2011","unstructured":"Gierut J, Zheng Y, Bie W, Carroll RE, Ball-Kell S, Haegebarth A, et al. Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane. Gastroenterology. 2011;141:1371\u201380.","journal-title":"Gastroenterology"},{"key":"8933_CR30","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1038\/onc.2011.608","volume":"31","author":"X Li","year":"2012","unstructured":"Li X, Lu Y, Liang K, Hsu JM, Albarracin C, Mills GB, et al. Brk\/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR. Oncogene. 2012;31:4372\u201383.","journal-title":"Oncogene"},{"key":"8933_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/1535-7163.MCT-18-0862","volume":"18","author":"DJ Wozniak","year":"2019","unstructured":"Wozniak DJ, Hitchinson B, Gilic MB, Bie W, Gaponenko V, Tyner AL. Vemurafenib Inhibits Active PTK6 in PTEN-null Prostate Tumor Cells. Mol Cancer Ther. 2019;18:937\u201346.","journal-title":"Mol Cancer Ther"},{"key":"8933_CR32","first-page":"1","volume":"8","author":"WM Alwanian","year":"2020","unstructured":"Alwanian WM, Tyner AL. Protein tyrosine kinase 6 signaling in prostate cancer. Am J Clin Exp Urol. 2020;8:1\u20138.","journal-title":"Am J Clin Exp Urol"},{"key":"8933_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.7150\/thno.49716","volume":"11","author":"HL Ang","year":"2021","unstructured":"Ang HL, Yuan Y, Lai X, Tan TZ, Wang L, Huang BB, et al. Putting the BRK on breast cancer: From molecular target to therapeutics. Theranostics. 2021;11:1115\u201328.","journal-title":"Theranostics"},{"key":"8933_CR34","doi-asserted-by":"publisher","first-page":"e1848","DOI":"10.1038\/cddis.2015.210","volume":"6","author":"M Peng","year":"2015","unstructured":"Peng M, Ball-Kell SM, Tyner AL. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse. Cell Death Dis. 2015;6:e1848.","journal-title":"Cell Death Dis"},{"key":"8933_CR35","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/stke.2712005re2","volume":"2005","author":"FM Boisvert","year":"2005","unstructured":"Boisvert FM, Chenard CA, Richard S. Protein interfaces in signaling regulated by arginine methylation. Sci STKE. 2005;2005:re2.","journal-title":"Sci STKE"},{"key":"8933_CR36","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.1073\/pnas.96.24.13738","volume":"96","author":"KF Harris","year":"1999","unstructured":"Harris KF, Shoji I, Cooper EM, Kumar S, Oda H, Howley PM. Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci USA. 1999;96:13738\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8933_CR37","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1128\/MCB.22.10.3316-3326.2002","volume":"22","author":"D Ungureanu","year":"2002","unstructured":"Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol. 2002;22:3316\u201326.","journal-title":"Mol Cell Biol"},{"key":"8933_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ncb2158","volume":"13","author":"JM Hsu","year":"2011","unstructured":"Hsu JM, Chen CT, Chou CK, Kuo HP, Li LY, Lin CY, et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol. 2011;13:174\u201381.","journal-title":"Nat Cell Biol"},{"key":"8933_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1182\/blood.2019001282","volume":"134","author":"X He","year":"2019","unstructured":"He X, Zhu Y, Lin YC, Li M, Du J, Dong H, et al. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD(+) acute myeloid leukemia. Blood. 2019;134:548\u201360.","journal-title":"Blood"},{"key":"8933_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104736","volume":"25","author":"E Hartsough","year":"2022","unstructured":"Hartsough E, Shelke RRJ, Amraei R, Aryan Z, Lotfollahzadeh S, Rahimi N. PRMT4-mediated arginine methylation promotes tyrosine phosphorylation of VEGFR-2 and regulates filopodia protrusions. iScience. 2022;25:104736.","journal-title":"iScience"},{"key":"8933_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31645-1","volume":"13","author":"L Huang","year":"2022","unstructured":"Huang L, Zhang XO, Rozen EJ, Sun X, Sallis B, Verdejo-Torres O, et al. PRMT5 activates AKT via methylation to promote tumor metastasis. Nat Commun. 2022;13:3955.","journal-title":"Nat Commun"},{"key":"8933_CR42","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45:D777\u2013D83.","journal-title":"Nucleic Acids Res"},{"key":"8933_CR43","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"8933_CR44","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980\u20135.","journal-title":"Nucleic Acids Res"},{"key":"8933_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2012.06.007","volume":"143","author":"S Ma","year":"2012","unstructured":"Ma S, Bao JYJ, Kwan PS, Chan YP, Tong CM, Fu L, et al. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology. 2012;143:675\u201386. e12.","journal-title":"Gastroenterology"},{"key":"8933_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0317-9","volume":"31","author":"YF Chen","year":"2014","unstructured":"Chen YF, Ma G, Cao X, Huang ZL, Zeng MS, Wen ZS. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma. Med Oncol. 2014;31:317.","journal-title":"Med Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08933-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08933-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:58:10Z","timestamp":1786406290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08933-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8933"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08933-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations and approved by the UIC Institutional Biosafety Committee. No human or animal subjects were used in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"706"}}